Ezetimibe and Simvastatin (Dr.Reddys Laboratories Inc)
Welcome to the PulseAid listing for the Ezetimibe and Simvastatin drug offered from Dr.Reddys Laboratories Inc. This HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA],Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Dr.Reddys Laboratories Inc |
| NON-PROPRIETARY NAME: | Ezetimibe and Simvastatin |
| SUBSTANCE NAME: | EZETIMIBE; SIMVASTATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA],Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-26 |
| END MARKETING DATE: | 0000-00-00 |
Ezetimibe and Simvastatin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ezetimibe and Simvastatin from Dr.Reddys Laboratories Inc |
| LABELER NAME: | Dr.Reddys Laboratories Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2017-04-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43598-583_84298866-72ea-5913-9946-d64036788662 |
| PRODUCT NDC: | 43598-583 |
| APPLICATION NUMBER: | ANDA200909 |
Other EZETIMIBE; SIMVASTATIN Pharmaceutical Manufacturers / Labelers:
